Cargando…
Strategies Aimed at Nox4 Oxidase Inhibition Employing Peptides from Nox4 B-Loop and C-Terminus and p22(phox) N-Terminus: An Elusive Target
Although NADPH oxidase 4 (Nox4) is the most abundant Nox isoform in systemic vascular endothelial and smooth muscle cells, its function in the vascular tissue is not entirely known. The literature describes a pathophysiological role for Nox4 in cardiovascular disease; however, some studies have repo...
Autores principales: | Csányi, Gábor, Pagano, Patrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626398/ https://www.ncbi.nlm.nih.gov/pubmed/23606947 http://dx.doi.org/10.1155/2013/842827 |
Ejemplares similares
-
CRISPR/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity
por: Prior, Kim-Kristin, et al.
Publicado: (2016) -
The NADPH Oxidase Nox4 and Aging in the Heart
por: Ago, Tetsuro, et al.
Publicado: (2010) -
Cytosolic PCNA interacts with p47phox and controls NADPH oxidase NOX2 activation in neutrophils
por: Ohayon, Delphine, et al.
Publicado: (2019) -
Implication of type 4 NADPH oxidase (NOX4) in tauopathy
por: Luengo, Enrique, et al.
Publicado: (2021) -
Correction: Cytosolic PCNA interacts with p47phox and controls NADPH oxidase NOX2 activation in neutrophils
por: Ohayon, Delphine, et al.
Publicado: (2019)